Cyclo Therapeutics, Inc.-Boca Raton Lunch

6000 Glades Road,Boca Raton FL 33431

19 May, 2022

Description

Come learn about Cyclo Therapeutics, Inc. (NASDAQ: CYTH) and their management team *Due to limited seating, please make sure each individual registers accordingly. You will not be permitted to attend the event without proper registration. Bear Creek Capital Presents:Cyclo Therapeutics, Inc. (NASDAQ:  CYTH)The Capital Grille6000 Glades RoadBoca Raton, FL 33431Thursday, May 19, 2022Promptly at 12:00 PM Join Cyclo Therapeutics, Inc. CEO & Director, Scott Fine for this exclusive corporate presentation, followed by a Q & A session moderated by Bear Creek Capital, featuring questions taken from the audience. About Cyclo Therapeutics, Inc.Cyclo Therapeutics, Inc. is a late clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is being studied in a Phase 3 pivotal clinical trial for Niemann-Pick Disease Type C, a rare and fatal genetic disease, (www.ClinicalTrials.gov NCT02939547, NCT02912793, NCT03893071 and NCT04860960). The Company is planning a Phase 2 clinical trial using Trappsol® Cyclo™ intravenously in Alzheimer’s Disease based on encouraging data from an Expanded Access program for late-onset Alzheimer’s Disease (NCT03624842). Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. In the NewsCyclo Therapeutics Enters Research and Collaboration Agreement with Wits Commercial Enterprise (Pty) Ltd to Explore Potential Applications of Trappsol® Cyclo™ to Expand Pipeline Presentation Format:  12:00 p.m. to 1:30 p.m. - Lunch & Company Presentation Contact: Raymond Oliver CEO, Bear Creek Capital 321-439-2120 [email protected]